Intellia Therapeutics (NTLA) Current Leases (2019 - 2025)
Historic Current Leases for Intellia Therapeutics (NTLA) over the last 7 years, with Q3 2025 value amounting to $27.4 million.
- Intellia Therapeutics' Current Leases rose 4276.48% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 4276.48%. This contributed to the annual value of $20.2 million for FY2024, which is 885.53% up from last year.
- Latest data reveals that Intellia Therapeutics reported Current Leases of $27.4 million as of Q3 2025, which was up 4276.48% from $27.0 million recorded in Q2 2025.
- Over the past 5 years, Intellia Therapeutics' Current Leases peaked at $38.8 million during Q1 2025, and registered a low of $7.4 million during Q2 2021.
- In the last 5 years, Intellia Therapeutics' Current Leases had a median value of $16.8 million in 2023 and averaged $16.9 million.
- As far as peak fluctuations go, Intellia Therapeutics' Current Leases surged by 885.53% in 2024, and later soared by 10659.28% in 2025.
- Quarter analysis of 5 years shows Intellia Therapeutics' Current Leases stood at $9.1 million in 2021, then surged by 83.11% to $16.7 million in 2022, then rose by 11.47% to $18.6 million in 2023, then rose by 8.86% to $20.2 million in 2024, then surged by 35.23% to $27.4 million in 2025.
- Its Current Leases was $27.4 million in Q3 2025, compared to $27.0 million in Q2 2025 and $38.8 million in Q1 2025.